Hearing on “The Obama Administration’s Medicare Drug Experiment: The Patient and Doctor Perspective,” Subcommittee on Health (May 17, 2016)
Date:
Location:
2123 Rayburn House Office Building
The Subcommittee on Health held a hearing on Tuesday, May 17, 2016, at 10:00 a.m. in 2123 Rayburn House Office Building. The hearing is entitled “The Obama Administration’s Medicare Drug Experiment: The Patient and Doctor Perspective.”
Livestream
Witnesses
Key Documents
Memorandum from Ranking Member Pallone to the Subcommittee on Health
Opening Statement of Ranking Member Pallone as prepared for delivery
Opening Statement of Health Subcommittee Ranking Member Green as prepared for delivery
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models
Meeting Documents
Witnesses
Debra Patt, MD, MPH, MBA
Vice President, Texas Oncology
Medical Director, The US Oncology Network
Chair, Clinical Practice Committee American Society of Clinical Oncology
Marcia Boyle
President and Founder
Immune Deficiency Foundation
Michael Schweitz, MD, FACP, MACR
National Advocacy Chair
Coalition of State Rheumatology Organizations
Heather Block
Patient Advocate
Joe Baker
President
Medicare Rights Center
Subcommittees
Issues:Health